Veterinary distributor MWI Veterinary Supply Co. will market the C-PET canine platelet enhancement therapy kit after signing an exclusive distribution agreement with C-PET developer Pall Corp., the companies announced today.
The kit, designed to treat dogs suffering from osteoarthritis and tendon and ligament injuries, will be sold under MWI’s Securos brand.
The disposable system uses filter-based technology to concentrate platelets and their associated growth factors from a patient’s blood. The portable kit does not require a power supply or use of a centrifuge and allows veterinarians to adjust the volume of blood used in the procedure to the size of the patient they are treating, according to Port Washington, N.Y.-based Pall Corp.
The company previously developed an equine platelet therapy kit called E-PET.
“Pall’s novel point-of-care cell harvesting and delivery method has been used to successfully treat tendinosis in horses,” said Jeffrey Schaffer, DVM, director of Pall Animal Health. “In adapting this technology for dogs, we worked closely with MWI to identify veterinarians interested in evaluating the product by treating osteoarthritic dogs and using a questionnaire to assess improvement in lameness.
“Over 100 dogs were treated and the improvement in lameness was judged to be statistically significant in animals expected to worsen with this progressive degenerative joint disease,” he added.
Pall Corp. also funded a clinical trial of C-PET, the results of which will be presented at the Veterinary Orthopedic Society conference on March 7, 2012, in Crested Butte, Colo.